Number of the records: 1
Apomorphine and the management of Parkinson's disease
SYS c030753 LBL ^^^^^nam^^22^^^^^^^^450^ 005 20041126131600.0 100 $a 20040531d2004 m y0sloc0103 ba 101 0-
$a eng 102 $a US 105 $a a or 000yy 200 1-
$a Apomorphine and the management of Parkinson's disease $f guest. eds. Mark Stacy, Stewart A. Factor 210 $a Hagerstown $c Lippincott Williams & Wilkins $d 2004 215 $a S36 s., il. $c tab. 225 2-
$a Neurology $v suppl. 4 $x 0028-3787 320 $a Obsahuje bibliografické odkazy 541 1-
$a Apomorfín a manažment Parkinsonovej choroby 606 1-
$a Parkinsonova choroba $x farmakoterapia $2 mesh $3 sllk_un_auth*d010300 $9 . 606 1-
$a apomorfín $x použitie terapeutické $x farmakokinetika $x metabolizmus $2 mesh $3 sllk_un_auth*d001058 $9 . 606 1-
$a injekcie subkutánne $2 mesh $3 sllk_un_auth*d007279 $9 . 675 $a 616.858-085:615.21 $v 2. $z slo 702 -1
$a Stacy $b Mark $3 sllk_un_auth*p0035880 $4 340 $p Movement Disorders Program, Duke University, Durham, North Carolina 702 -1
$a Factor $b Stewart A. $3 sllk_un_auth*p0035881 $4 340 $p Parkinson's Disease and Movement Disorders Center of Albany Medical Center, Albany, New York 712 02
$a American Academy of Neurology $3 sllk_un_auth*k0000007 $4 070 801 -0
$a SK $b BA006 $c 20040531 $g AACR2
Number of the records: 1